[1] |
ZHANG Yunuo, LI Ruibin, WANG Wei.
Correlation Analysis of Serum Nesfatin-1 and Ghrelin Levels with Glycolipid Metabolism and Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2025, 28(26): 3264-3270.
|
[2] |
ZHANG Ruimin, DONG Zheyi, LI Shuang, WANG Qian, CHEN Xiangmei.
Traditional Chinese Medicine Factors Associated with Diabetic Nephropathy Diagnosed by Renal Biopsy
[J]. Chinese General Practice, 2025, 28(26): 3307-3313.
|
[3] |
TANG Shangfeng, HUANG Yangzhen, ZHENG Yanxi, PAN Yangyang, XIONG Zhongbao, QING Hua, SONG Jia, WEI Yilin, DONG Heng, WANG Chunying, CHEN Manwei, ZHANG Kangkang.
Specification for the Integration of Healthcare and Prevention Services in Diabetes at the Primary Level
[J]. Chinese General Practice, 2025, 28(25): 3096-3103.
|
[4] |
YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan.
Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes
[J]. Chinese General Practice, 2025, 28(24): 3053-3058.
|
[5] |
WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening.
Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention
[J]. Chinese General Practice, 2025, 28(24): 2985-2992.
|
[6] |
LIU Yueying, WANG Xueli, LIU Yuqiu, WEI Limin.
Correlation of Fasting C-peptide to Diabetes Duration Ration and Type 2 Diabetes Mellitus Combined with Metabolism-related Fatty Liver Disease
[J]. Chinese General Practice, 2025, 28(23): 2852-2860.
|
[7] |
WANG Peng, QIU Lixia, XU Shanshan, ZHANG Yang, ZHANG Jing, DU Xiaofei.
Advances in the Co-management of Metabolism Dysfunction-associated Fatty Liver Disease and Type 2 Diabetes Mellitus
[J]. Chinese General Practice, 2025, 28(23): 2846-2851.
|
[8] |
BAI Xue, CHEN Qianqian, LI Jie.
Innovative Practices in Chronic Disease Management: a New Model for Generalist-Specialist Combination Management of Diabetes and Metabolic Dysfunction-associated Fatty Liver Disease
[J]. Chinese General Practice, 2025, 28(23): 2841-2845.
|
[9] |
TANG Xiaorui, XU Jingjing, GU Zijun, WANG Qingyu, LIN Zheng, ZHU Qiurui, LEI Yang.
The Reliability and Validity of the Chinese Version of Self-Care of Diabetes Inventory
[J]. Chinese General Practice, 2025, 28(21): 2643-2651.
|
[10] |
WANG Ying, YAN Yijun, LIU Lei, HU Yumin, ZHANG Yang, LIU Kai, JIANG Boren.
Effects of Resistance Exercise Combined with Nutritional Intervention on Blood Glucose Stability in Elderly Patients with Type 2 Diabetes Mellitus with Sarcopenia
[J]. Chinese General Practice, 2025, 28(21): 2604-2610.
|
[11] |
MA Panpan, WANG Sijing, YOU Na, DING Dafa, LU Yibing.
Efficacy and Safety of Danuglipron and Orforglipron in the Treatment of Type 2 Diabetes Mellitus: a Meta-analysis
[J]. Chinese General Practice, 2025, 28(21): 2679-2685.
|
[12] |
JIN Yan, YANG Yang, WANG Lulu, ZHENG Qingwan, LI Xinyan, ZHANG Ning.
Effects of Exercise Training after Bariatric Surgery on Cardiopulmonary Function in Patients with Type 2 Diabetes Mellitus and Obesity: a Randomized Controlled Trial
[J]. Chinese General Practice, 2025, 28(21): 2611-2617.
|
[13] |
FU Rong, SHI Lei, HE Feiying.
Comorbidity of Diabetes and Depression in Middle-aged and Elderly People: the Impact of Sleep, Exercise, and Social Activities
[J]. Chinese General Practice, 2025, 28(20): 2491-2500.
|
[14] |
HUANG Zhijie, MAI Zhihua, WANG Haoxiang, HE Yuming, DENG Qiaoyan, DAI Ranran, ZHOU Zhiheng.
Multimorbidity of Hypertension, Diabetes, and Dyslipidemia and Influencing Factors of Family Function among the Elderly
[J]. Chinese General Practice, 2025, 28(16): 2001-2010.
|
[15] |
ZHAO Xiaoxiao, KE Lixin, XUN Yangqin, WANG Haibo, GAO Wulin, QIAO Tianci, LU Xiaohui, WU Jibiao, LU Cuncun.
Investigation and Future Trend Prediction of Disease Burden of Elderly Type 2 Diabetes Mellitus Globally and in China from 1990 to 2021
[J]. Chinese General Practice, 2025, 28(16): 2050-2058.
|